Form 4 Filing for Thomas Haughey

Thomas Haughey, a director at ANI Pharmaceuticals Inc., reported a transaction on May 21, 2026, involving the acquisition of 4,357 shares of Common Stock through a restricted stock award that will vest fully on May 21, 2027. The award had a transaction price of $0.00 per share, resulting in a post-transaction ownership of 40,878 shares. Subsequently, on June 8, 2026, Haughey sold 2,000 shares of Common Stock at a price of $80.88 per share, as per a Rule 10b5-1 trading plan. This sale reduced his post-transaction share count to 38,878. The transactions were electronically signed by his attorney-in-fact on June 10, 2026.